Autophagy: a multifaceted player in the fate of sperm
M Wang, L Zeng, P Su, L Ma, M Zhang… - Human Reproduction …, 2022 - academic.oup.com
BACKGROUND Autophagy is an intracellular catabolic process of degrading and recycling
proteins and organelles to modulate various physiological and pathological events …
proteins and organelles to modulate various physiological and pathological events …
Perfect match: mTOR inhibitors and tuberous sclerosis complex
C Luo, WR Ye, W Shi, P Yin, C Chen, YB He… - Orphanet journal of rare …, 2022 - Springer
Tuberous sclerosis complex (TSC) is an autosomal dominant syndrome that presents with
diverse and complex clinical features and involves multiple human systems. TSC-related …
diverse and complex clinical features and involves multiple human systems. TSC-related …
[HTML][HTML] Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations
Background Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disease
affecting multiple body systems with wide variability in presentation. In 2013, Pediatric …
affecting multiple body systems with wide variability in presentation. In 2013, Pediatric …
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease
LM Byrne, FB Rodrigues, EB Johnson… - Science translational …, 2018 - science.org
Huntington's disease (HD) is a genetic progressive neurodegenerative disorder, caused by
a mutation in the HTT gene, for which there is currently no cure. The identification of …
a mutation in the HTT gene, for which there is currently no cure. The identification of …
COX7A1 enhances the sensitivity of human NSCLC cells to cystine deprivation-induced ferroptosis via regulating mitochondrial metabolism
Y Feng, J Xu, M Shi, R Liu, L Zhao, X Chen, M Li… - Cell death & …, 2022 - nature.com
COX7A1, a subunit of cytochrome c oxidase, holds an important position in the super-
assembly which integrates into multi-unit heteromeric complexes peripherally in the …
assembly which integrates into multi-unit heteromeric complexes peripherally in the …
Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life
DE Greydanus, R Azmeh, MD Cabral, CA Dickson… - Disease-a-Month, 2021 - Elsevier
Acne vulgaris is a chronic, inflammatory, skin condition that involves the pilosebaceous
follicles and is influenced by a variety of factors including genetics, androgen-stimulation of …
follicles and is influenced by a variety of factors including genetics, androgen-stimulation of …
What's new in photoprotection: a review of new concepts and controversies
DG Yeager, HW Lim - Dermatologic clinics, 2019 - derm.theclinics.com
Cumulative UV radiation (UVR) exposure plays a critical role in photoaging,
immunosuppression, photocarcinogenesis and the exacerbation of photodermatoses. UV-A …
immunosuppression, photocarcinogenesis and the exacerbation of photodermatoses. UV-A …
PI3K/mTOR pathway inhibition: opportunities in oncology and rare genetic diseases
P Hillmann, D Fabbro - International journal of molecular sciences, 2019 - mdpi.com
The phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) signaling
pathway has been implicated as a cancer target. Big pharma players and small companies …
pathway has been implicated as a cancer target. Big pharma players and small companies …
Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis
M Li, Y Zhou, C Chen, T Yang, S Zhou, S Chen… - Orphanet Journal of …, 2019 - Springer
Background The treatment of tuberous sclerosis complex (TSC) using mammalian target of
rapamycin (mTOR) inhibitors is clinically promising. The aim of the present study was to …
rapamycin (mTOR) inhibitors is clinically promising. The aim of the present study was to …
TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex
N Alesi, D Khabibullin, DM Rosenthal, EW Akl… - Nature …, 2024 - nature.com
Abstract Tuberous Sclerosis Complex (TSC) is caused by TSC1 or TSC2 mutations, leading
to hyperactivation of mechanistic target of rapamycin complex 1 (mTORC1) and lesions in …
to hyperactivation of mechanistic target of rapamycin complex 1 (mTORC1) and lesions in …